title: Efficacy of Rechallenge of Metastatic Renal Cell Carcinoma Patient With Sunitinib After Prior Resistance to Axitinib: Case Report and Review of the Literature.
authors.affiliation: Department of Medical Oncology, Hôpital Saint-André, University of Bordeaux-CHU Bordeaux, France; University of Bordeaux, Bordeaux, France. Electronic address: amaury.daste@chu-bordeaux.fr.
authors.forename: Amaury
authors.initials: A
authors.lastname: Daste
authors.affiliation: Department of Medical Oncology, Hôpital Saint-André, University of Bordeaux-CHU Bordeaux, France.
authors.forename: Marine
authors.initials: M
authors.lastname: Gross-Goupil
authors.affiliation: Department of Medical Oncology, Hôpital Saint-André, University of Bordeaux-CHU Bordeaux, France.
authors.forename: Amandine
authors.initials: A
authors.lastname: Quivy
authors.affiliation: Department of Medical Oncology, Hôpital Saint-André, University of Bordeaux-CHU Bordeaux, France; University of Bordeaux, Bordeaux, France.
authors.forename: Louis
authors.initials: L
authors.lastname: François
authors.affiliation: Department of Urology, Hôpital Pellegrin, University of Bordeaux-CHU Bordeaux, France.
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Bernhard
authors.affiliation: Department of Medical Oncology, Hôpital Saint-André, University of Bordeaux-CHU Bordeaux, France; University of Bordeaux, Bordeaux, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Ravaud
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000077784:Axitinib; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007191:Indazoles / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D007093:Imidazoles; D007191:Indazoles; D007211:Indoles; D011758:Pyrroles; D000077784:Axitinib; D000077210:Sunitinib
keywords: Axitinib; Metastatic renal cell carcinoma; Rechallenge; Tyrosine kinase inhibitor; VEGF-R targeted therapy